Prognosis

Johnson & Johnson Covid-19 Vaccine Cleared for Use in U.S.

Single-dose vaccine expands U.S. immunization arsenal
Shot seen as easier to distribute, administer than rivals

Watch: White House officials say Johnson & Johnson will ship 3.9 million doses of its vaccine after it was approved for use in the U.S. over the weekend. (Source: Bloomberg)

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Riley Griffin

February 27, 2021 at 11:14 PM UTC

Updated on

February 28, 2021 at 12:05 AM UTC

This article is for subscribers only.

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

Johnson & Johnson’s coronavirus vaccine was cleared for use in the U.S., making a third shot available that could plug gaps in the nation’s immunization campaign as concern grows over an influx of virus variants.